MedPath

Gacyclidine

Generic Name
Gacyclidine
Drug Type
Small Molecule
Chemical Formula
C16H25NS
CAS Number
68134-81-6
Unique Ingredient Identifier
9290ND070R
Background

Gacyclidine has been used in trials studying the treatment of Tinnitus.

Clinical Trials
Related News

OTO-313 in Subjects With Unilateral Subjective Tinnitus

Phase 2
Completed
Conditions
Subjective Tinnitus
Interventions
Drug: Placebo
First Posted Date
2021-04-02
Last Posted Date
2023-01-06
Lead Sponsor
Otonomy, Inc.
Target Recruit Count
153
Registration Number
NCT04829214
Locations
🇺🇸

ChicagoENT, Chicago, Illinois, United States

🇵🇱

Centrum Medyczne ZDROWA, Kraków, Poland

🇺🇸

Dartmouth-Hitchcock Medical Center/Mary Hitchcock Memorial Hospital, Lebanon, New Hampshire, United States

and more 43 locations

OTO-313 in Subjects With Subjective Tinnitus

Phase 1
Completed
Conditions
Tinnitus, Subjective
Interventions
Drug: Placebo
First Posted Date
2019-04-17
Last Posted Date
2022-12-23
Lead Sponsor
Otonomy, Inc.
Target Recruit Count
43
Registration Number
NCT03918109
Locations
🇺🇸

WVU Medicine, Morgantown, West Virginia, United States

🇺🇸

Silverstein Institute/Ear Research Foundation, Sarasota, Florida, United States

🇺🇸

California Head & Neck Specialists, San Diego, California, United States

and more 13 locations
© Copyright 2025. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy